This side effect was reported in human patients diagnosed with breast cancer, where the G-CSF administration produced a significant reduction in mean haemoglobin concentration and anaemia, progressively worsening with increasing dosage of the product [57], also mentioned by the manufacturer [39]. This evidence concerns the gene CSF3 and breast carcinoma.